Complete Response of Anaplastic Lymphoma Kinase–Mutated Refractory Extranodal Natural Killer/T-Cell Lymphoma to Crizotinib

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1319-1320
Number of pages2
JournalMayo Clinic Proceedings
Volume91
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Natural Killer T-Cells
T-Cell Lymphoma
crizotinib
anaplastic lymphoma kinase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{5e2685e21901483eb33aa6846adbbc49,
title = "Complete Response of Anaplastic Lymphoma Kinase–Mutated Refractory Extranodal Natural Killer/T-Cell Lymphoma to Crizotinib",
author = "Gita Thanarajasingam and Eric Edell and Markovic, {Svetomir Nenad}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.mayocp.2016.06.014",
language = "English (US)",
volume = "91",
pages = "1319--1320",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Complete Response of Anaplastic Lymphoma Kinase–Mutated Refractory Extranodal Natural Killer/T-Cell Lymphoma to Crizotinib

AU - Thanarajasingam, Gita

AU - Edell, Eric

AU - Markovic, Svetomir Nenad

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84991013965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991013965&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2016.06.014

DO - 10.1016/j.mayocp.2016.06.014

M3 - Letter

C2 - 27594191

AN - SCOPUS:84991013965

VL - 91

SP - 1319

EP - 1320

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -